Author's posts
Market Muscle: Study Uncovers Differences Between Medicare And Private Insurers
Findings released Thursday by the Rand Corp. highlight how reimbursement rates vary nationally and the impact the charges have on the nation’s high cost of health care.
Booker’s Argument For Environmental Justice Stays Within The Lines
He didn’t overstate the relationship between hazardous waste sites and birth defects and autism.
CBO’s Report On Single-Payer Health Care Holds More Questions Than Answers
The Congressional Budget Office report does clearly communicate that shifting to this type of health system would be a complicated process.
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
Mulvaney: Trump Brought Down Drug Prices For The First Time In 50 Years
It’s “within spitting distance of something that’s true,” said one health economist. But our fact check found it wasn’t quite there.
As Sanders Officially Revives Medicare-For-All, Plan B For Democrats Gains Traction
“Medicare for America” seeks to avoid some of the predictable obstacles of a full-blown expansion of Medicare. Can it survive the politics of health reform?
Health Officials’ Plug For Next FDA Chief: Go Big On E-Cig Regulation
With Scott Gottlieb making his exit from the Food and Drug Administration’s top spot, city and country health officials call for backup in the fight to curb teen use of e-cigarettes.
There’s A New ‘Medicare-For-All’ Bill In The House. Why Does It Matter?
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nation’s health system, and Democratic primary candidates will have to be prepared to get more specific.
For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
